US Broker Ratings

Viant Technology Inc. (DSP) Stock Analysis: Insights into a Potential 53% Upside for Tech Investors

Viant Technology Inc. (NASDAQ: DSP) has garnered significant attention in the tech investment community, and for good reason. With a market capitalization of $887.82 million, the..

Cytek Biosciences (CTKB) Stock Analysis: 60% Potential Upside Amid Healthcare Innovations

Cytek Biosciences, Inc. (NASDAQ: CTKB) stands as a notable player in the healthcare sector, particularly within the medical devices industry. With a market capitalization of $453.44..

Grab Holdings Limited (GRAB) Stock Analysis: Strong Buy Ratings and 16% Potential Upside

Grab Holdings Limited (GRAB), a dominant player in the Southeast Asian “superapp” space, continues to capture investor attention with its diverse service offerings across mobility, deliveries,..

Pacific Biosciences of California (PACB) Stock Analysis: Is the 38.85% Potential Upside Worth the Risk?

Pacific Biosciences of California, Inc. (NASDAQ: PACB) is a prominent player in the healthcare sector, specifically within the medical devices industry. The company, headquartered in Menlo..

Alpha Tau Medical Ltd. (DRTS): Investor Outlook Reveals 168% Potential Upside with Promising Oncology Innovations

Alpha Tau Medical Ltd. (NASDAQ: DRTS), headquartered in Jerusalem, Israel, is carving a niche in the healthcare sector with its innovative approach to oncology therapeutics. Focused..

Marti Technologies, Inc. (MRT) Stock Analysis: A Look at the 78% Upside Potential

Marti Technologies, Inc. (NASDAQ: MRT) is attracting attention in the investment community, driven by its innovative approach to urban transportation in Turkey and an enticing 78%..

Compass Therapeutics, Inc. (CMPX) Stock Analysis: Unveiling a Potential 382% Upside

Compass Therapeutics, Inc. (NASDAQ: CMPX), a clinical-stage biopharmaceutical company based in Boston, Massachusetts, is capturing the attention of investors with its innovative approach in the biotechnology..

Fulcrum Therapeutics, Inc. (FULC) Stock Analysis: Biotech Innovator Positioned for Growth Amidst Clinical Advances

Fulcrum Therapeutics, Inc. (NASDAQ: FULC) is gaining traction in the biotechnology sector with its innovative approach to targeting genetically defined diseases. This clinical-stage biopharmaceutical company, headquartered..

Aurora Cannabis Inc. (ACB): Investor Outlook Highlights Revenue Growth and Analyst Ratings

Aurora Cannabis Inc. (ACB), a prominent player in the healthcare sector, specializes in the production, distribution, and sale of cannabis and cannabis-derivative products. With its headquarters..

Arcturus Therapeutics Holdings (ARCT) Stock Analysis: A Biotech Gem with 355% Upside Potential

For investors with a keen eye on the biotechnology sector, Arcturus Therapeutics Holdings (NASDAQ: ARCT) presents an intriguing opportunity. With a market capitalization of $401.11 million,..

Varex Imaging Corporation (VREX) Stock Analysis: A Healthcare Imaging Leader With Nearly 97% Potential Upside

Varex Imaging Corporation (NASDAQ: VREX) stands as a notable player in the healthcare sector, particularly within the medical devices industry. The company, headquartered in Salt Lake..

TotalEnergies SE (TTE) Stock Analysis: A Strong Dividend Play with a 10.96% Upside Potential

TotalEnergies SE (TTE) stands as a formidable player in the global energy sector, offering a diverse portfolio that spans oil, biofuels, natural gas, and renewable energy..

Neuronetics, Inc. (STIM) Stock Analysis: Exploring a 95% Potential Upside in the Medical Device Sector

Neuronetics, Inc. (NASDAQ: STIM), a key player in the medical device industry, is capturing investor attention with its innovative approach to treating neurohealth disorders and a..

Gossamer Bio, Inc. (GOSS) Stock Report: Analysts See a Potential Upside of 459%—Is It Worth the Risk?

Gossamer Bio, Inc. (NASDAQ: GOSS), a clinical-stage biopharmaceutical company headquartered in San Diego, California, operates within the healthcare sector, focusing on groundbreaking treatments for pulmonary arterial..

Candel Therapeutics, Inc. (CADL) Stock Analysis: A Promising 261% Upside Potential with Robust Analyst Support

Candel Therapeutics, Inc. (NASDAQ: CADL), a clinical-stage biopharmaceutical company, is making waves in the biotechnology sector with its promising portfolio of cancer immunotherapies. Headquartered in Needham,..

XOMA Royalty Corporation (XOMA) Stock Analysis: A Biotech Gem with 133% Potential Upside

As investors sift through the myriad opportunities in the healthcare sector, XOMA Royalty Corporation (NASDAQ: XOMA) stands out with a compelling growth narrative anchored by a..

NANO-X IMAGING LTD (NNOX): Investor Outlook Reveals 67.95% Potential Upside in the Innovative Medical Imaging Sector

Nano-X Imaging Ltd (NASDAQ: NNOX) is capturing investor attention with its groundbreaking approach to medical imaging technology. Headquartered in Petah Tikva, Israel, this trailblazer in the..

National Research Corporation (NRC) Stock Analysis: A High ROE Healthcare Play with a 2.86% Dividend Yield

National Research Corporation (NRC), a key player in the healthcare sector, specializes in providing analytics and insights designed to enhance the patient and employee experience. With..

Exxon Mobil Corporation (XOM) Stock Analysis: Assessing a 9% Potential Upside

Exxon Mobil Corporation (NYSE: XOM), a titan in the energy sector, continues to be a focal point for investors seeking stability and growth in the oil..

Investor Outlook: Anbio Biotechnology (NNNN) – Navigating a Volatile Path in the Medical Instruments Sector

Anbio Biotechnology (NNNN), a burgeoning player in the medical instruments and supplies industry, is capturing attention with its rapid ascent in the stock market. Based in..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds